MCID: END057
MIFTS: 75

Endometrial Cancer malady

Categories: Genetic diseases (common), Cancer diseases, Reproductive diseases

Aliases & Classifications for Endometrial Cancer

About this section

Aliases & Descriptions for Endometrial Cancer:

Name: Endometrial Cancer 50 46 68 12 48
Endometrial Carcinoma 11 13 25 12 48 66
Endometrial Carcinoma, Somatic 50 23
Carcinoma, Endometrioid 37 66
Endometrioid Carcinoma of Female Reproductive System 11
Malignant Neoplasm of Endometrium 66
 
Endometrial Cancer, Familial 50
Carcinoma of the Endometrium 11
Endometrioid Carcinoma 11
Uterine Corpus Cancer 66
Endometrial Neoplasms 37
Endmc 68

Classifications:



External Ids:

OMIM50 608089
Disease Ontology11 DOID:2871
NCIt43 C3769, C7558
MedGen35 C0476089
ICD1028 C54.1

Summaries for Endometrial Cancer

About this section
UniProtKB/Swiss-Prot:68 Endometrial cancer: A malignancy of endometrium, the mucous lining of the uterus. Most endometrial cancers are adenocarcinomas, cancers that begin in cells that make and release mucus and other fluids.

MalaCards based summary: Endometrial Cancer, also known as endometrial carcinoma, is related to adenosquamous carcinoma and adenomyosis, and has symptoms including endometrial carcinoma An important gene associated with Endometrial Cancer is PTEN (Phosphatase And Tensin Homolog), and among its related pathways are Mismatch repair and Vemurafenib Pathway, Pharmacodynamics. Affiliated tissues include the tissue lining the uterus, breast and uterus, and related mouse phenotypes are pigmentation and hearing/vestibular/ear.

Disease Ontology:11 A endometrial cancer that is located in the tissue lining the uterus.

Wikipedia:69 Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It... more...

Description from OMIM:50 608089

Related Diseases for Endometrial Cancer

About this section

Diseases related to Endometrial Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 301)
idRelated DiseaseScoreTop Affiliating Genes
1adenosquamous carcinoma32.3EGFR, ERBB2, KRAS, PIK3CA
2adenomyosis31.8CTNNB1, EGFR, ERBB2
3breast cancer31.2CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
4colorectal cancer30.4CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
5uterine corpus endometrial carcinoma12.0
6ovarian endometrial cancer11.9
7endometrioid ovary carcinoma11.3
8large intestine adenocarcinoma11.3MLH1, MSH2, MSH6
9neuropathy, distal hereditary motor, type viib11.3MLH1, MSH2, MSH6
10gelatinous ascites11.3ERBB2, ESR1, PGR
11colver steer godman syndrome11.3CDH1, MLH1, MSH2, TP53
12amyloid tumor11.3CCND1, ESR1, PGR, PTEN
13sleeping sickness11.3MLH1, MSH3, MSH6
14hereditary essential tremor 511.3KRAS, MLH1, MSH2, MSH6
15cholesteatoma of external ear11.3ERBB2, ESR1, PGR, TP53
16angioimmunoblastic lymphadenopathy with dysproteinemia11.3EGF, MLH1, MSH2
17trigeminal nerve disease11.3ERBB2, ESR1, PGR
18glottis verrucous carcinoma11.2EGFR, ERBB2, ESR1, PGR
19spleen angiosarcoma11.2EGF, ESR1, MLH1, MSH2, MSH6
20cell type benign neoplasm11.2ERBB2, ESR1, PGR, TP53
21bladder colonic type adenocarcinoma11.2EGFR, ERBB2, ESR1, PGR
22cartilage cancer11.2ERBB2, ESR1, PGR, TP53
23lymphoplasmacytic lymphoma11.2MLH1, MSH2, MSH6, PTEN, TP53
24ossifying fibromyxoid tumor11.2EGFR, ERBB2, PGR
25adenocarcinoma in situ11.2ERBB2, ESR1, PGR
26leiomyosarcoma11.2ERBB2, ESR1, PGR, TP53
27breast adenoma11.2ERBB2, ESR1, PGR, TP53
28animal phobia11.2EGFR, ERBB2, PGR, TP53
29her2-receptor negative breast cancer11.2EGFR, ERBB2, PGR
30nerve fibre bundle defect11.2ERBB2, ESR1, PGR, TP53
31uterine body mixed cancer11.2ESR1, PGR, TP53
32bartholin's gland adenoid cystic carcinoma11.2EGFR, ESR1, PGR
33anomalous left coronary artery from the pulmonary artery11.2EGFR, ERBB2, ESR1, PGR
34cervical adenomyoma11.2CTNNB1, MLH1, MSH2
35vulval paget's disease11.2ERBB2, ESR1, PGR, TP53
36mismatch repair cancer syndrome11.2CTNNB1, MLH1, MSH2, MSH6, PTEN
37gallbladder squamous cell carcinoma11.2CCND1, ESR1, PGR
38food allergy11.2MLH1, MSH2, MSH6
39tamoxifen-related endometrial lesion11.2EGFR, PIK3CA, TP53
40pyoderma11.2KRAS, MLH1, PIK3CA, TP53
41optic papillitis11.2CCND1, KRAS, MLH1, MSH2, MSH6
42mixed cerebral palsy11.2ERBB2, ESR1, PGR, TP53
43lung carcinoma in situ11.2ERBB2, ESR1, PGR, TP53
44pleomorphic carcinoma11.2EGFR, ERBB2, ESR1, PGR
45fallopian tube mucinous adenocarcinoma11.2EGFR, ERBB2, ESR1, TP53
46gastric squamous cell carcinoma11.2CDH1, EGFR, ERBB2
47tumor predisposition syndrome11.2CDH1, MLH1, MSH2, MSH6, PTEN, TP53
48vibratory urticaria11.2ERBB2, ESR1, KRAS, PGR, TP53
49distal monosomy 9p11.2EGFR, ERBB2, PGR, TP53
50vaginal adenosarcoma11.2ERBB2, PGR, PIK3CA

Graphical network of the top 20 diseases related to Endometrial Cancer:



Diseases related to endometrial cancer

Symptoms for Endometrial Cancer

About this section


Clinical features from OMIM:

608089

HPO human phenotypes related to Endometrial Cancer:

id Description Frequency HPO Source Accession
1 endometrial carcinoma HP:0012114

Drugs & Therapeutics for Endometrial Cancer

About this section

Drugs for Endometrial Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 219)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DaidzeinPhase 412486-66-85281708
Synonyms:
4',7-Dihydroxy-Isoflavone
4',7-Dihydroxyisoflavone
 
7,4'-Dihydroxyisoflavone
7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
Daidzeol
Isoaurostatin
2
TamoxifenPhase 4, Phase 3, Phase 2, Phase 136810540-29-12733526
Synonyms:
(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene
(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine
(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC)
(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE
(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
,citrate
1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
10540-29-1
1ya4
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
54965-24-1 (citrate)
AC1MBZ3R
Apo-Tamox
Apo-tamox
BIDD:ER0008
BIDD:GT0009
BIDD:PXR0003
BPBio1_000278
BRD-K93754473-001-02-9
BRD-K93754473-048-05-3
BSPBio_000252
BSPBio_001150
BSPBio_001982
C07108
C26H29NO
CCRIS 3275
CHEBI:41774
CHEMBL83
CID2733526
Citofen
Crisafeno
D08559
DB00675
Diemon
EINECS 234-118-0
Gen-Tamoxifen
Gen-tamoxifen
HMS1362J11
HMS1792J11
HMS1990J11
HMS2090N08
HSDB 6782
ICI 47699
ICI-46,474
ICI-47699
IDI1_000258
IDI1_002170
Istubol
Kessar
L024126
LS-393
Lopac0_001203
MLS001332535
MLS001332536
MolPort-003-850-384
 
NCGC00024928-01
NCGC00024928-03
NCGC00024928-04
NCGC00024928-05
NCGC00024928-07
NCGC00024928-08
NCGC00024928-09
NCGC00024928-12
NSC727681
Noltam
Nolvadex
Nolvadex-D
Nourytam
Novaldex
Novo-Tamoxifen
Oncomox
PMS-Tamoxifen
Pms-Tamoxifen
Prestwick2_000146
Prestwick3_000146
QTL1_000079
Retaxim
SMR000059172
ST50511785
Spectrum5_001417
Spectrum5_002043
T5648_SIGMA
TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1))
TRANS FORM OF TAMOXIFEN
Tamizam
Tamofen
Tamone
Tamoplex (TN)
Tamoxasta
Tamoxen
Tamoxifen
Tamoxifen (INN)
Tamoxifen (TN)
Tamoxifen (Z)
Tamoxifen Citrate
Tamoxifen [INN:BAN]
Tamoxifen and its salts
Tamoxifene
Tamoxifene [INN-French]
Tamoxifeno
Tamoxifeno [INN-Spanish]
Tamoxifenum
Tamoxifenum [INN-Latin]
Tamoxifène
Tocris-0999
Tomaxithen
Trans-Tamoxifen
UNII-094ZI81Y45
UPCMLD-DP027
Valodex
Zemide
cMAP_000044
nchembio.140-comp7
nchembio.76-comp1
nchembio732-comp3
tamoxifen
trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
trans-Tamoxifen
3
BenzocainePhase 4, Phase 217941994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
4
ManganesePhase 4337439-96-527854
Synonyms:
 
Manganese
5insulinPhase 4, Phase 24401
6
ProgesteronePhase 4, Phase 3, Phase 2, Phase 1, Phase 051557-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
7
LetrozolePhase 4, Phase 3, Phase 2, Phase 0368112809-51-53902
Synonyms:
1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole
1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole
112809-51-5
4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)
4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile
4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole
4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile
4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile
4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile
4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
AB00514009
AC-1193
AC1L1GYT
AKOS005145822
BIDD:GT0015
BIDD:PXR0130
BPBio1_001331
BRD-K88789588-001-03-2
BSPBio_001209
Bio-0057
C067431
C08163
C17H11N5
CAS-112809-51-5
CCRIS 8822
CGS 20267
CGS 20267, Femara, Piroxicam, Letrozole
CGS-20267
CHEBI:6413
CHEMBL1444
CID3902
CPD000466343
D00964
 
DB01006
FEM-345
Femara
Femara (TN)
Femera
HMS1571M11
HMS2051E08
HMS2089L22
HSDB 7461
I06-0022
LS-38788
Letoval
Letrozol
Letrozole
Letrozole (JAN/USP/INN)
Letrozole [USAN:INN]
MLS000759455
MLS001424038
MLS002584991
MolPort-003-848-373
NCGC00016973-01
NCGC00016973-02
NSC719345
Novartis Brand of Letrozole
Prestwick0_001025
Prestwick1_001025
Prestwick2_001025
Prestwick3_001025
S1235_Selleck
SAM001246649
SMR000466343
SPBio_003070
TL8000371
UNII-7LKK855W8I
ZINC03778874
letrozole
8
Megestrol acetatePhase 4, Phase 3, Phase 2, Phase 164595-33-511683
Synonyms:
17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate
17alpha-Acetoxy-6-dehydro-6-methylprogesterone
17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate
17α-Acetoxy-6-dehydro-6-methylprogesterone
17α-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate
6-Dehydro-6-methyl-17alpha-acetoxyprogesterone
6-Dehydro-6-methyl-17α-acetoxyprogesterone
6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione
 
6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate
6-Methyl-17α-acetoxypregna-4,6-diene-3,20-dione
6-Methyl-17α-hydroxy-delta(sup 6)-progesterone acetate
6-Methyl-6-dehydro-17alpha-acetoxyprogesterone
6-Methyl-6-dehydro-17α-acetoxyprogesterone
6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate
6-Methyl-delta(sup 4,6)-pregnadien-17α-ol-3,20-dione acetate
6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone
6-Methyl-delta(sup 6)-dehydro-17α-acetoxyprogesterone
MGA
Megace
9
EstradiolPhase 4, Phase 2, Phase 3, Phase 0125050-28-25757, 53477783
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate
1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta-Estradiol
17-.BETA.-Estradiol
17-E
17-beta
17-beta-OH-estradiol
17-beta-estradiol
17.beta.-Estradiol
17.beta.-Oestradiol
17E
17b-Estradiol
17b-Oestradiol
17beta Oestradiol
17beta oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17beta-Estradiol
17beta-Oestradiol
1jgl
1qkt
1qku
2d06
3,17-Epidihydroxyestratriene
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
B-Estradiol
BEDOs
BIDD:ER0125
BIDD:PXR0065
BPBio1_000532
BSPBio_000482
BSPBio_001065
Bardiol
Benzhormovarine
Beta-estradiol
Bio-0812
Bio-E-Gel
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
CMC_11154
CPD-352
CPD000059126
Climaderm
Climara
Climara (TN)
Climara Forte
Compudose
Compudose 200
Compudose 365
Corpagen
D-3,17beta-Estradiol
D-Estradiol
D-Oestradiol
D00105
DB00783
Dermestril
Destradiol
Dihydro-Theelin
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
EU-0100503
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
Estradiol
Estradiol [USAN:INN]
Estradiol-17 beta
Estradiol-17-beta
Estradiol-17.beta.
Estradiol-17beta
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring Vaginal Ring
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
Estrofem Forte
Estrogel
 
Estrogel (TN)
Estrogel HBF
Estrovite
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
GynPolar
Gynergon
Gynestrel
Gynodiol
Gynoestryl
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
LMST02010001
LS-137
Lamdiol
Lio-Oid
Lopac0_000503
MLS000069494
MLS000758312
MLS001076331
Macrodiol
Macrol
Menest
Menorest
Menostar
Microdiol
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
NSC-9895
NSC9895
Nordicol
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17-beta
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Prestwick_207
Primofol
Profoliol
Profoliol B
Progynon
Progynon DH
Progynon-DH
S-21400
S1709_Selleck
SAM001247032
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Sandrena 1
Sandrena Gel
Sisare Gel
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
VIVELLE-DOT
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
Zerella
Zesteem
Zesteen
Zumenon
[2,4,6,7-3H]-E2
[3H]-estradiol
[3H]]estradiol
b-Estradiol
beta-Estradiol
beta-Estradiol 3-sulfate
beta-Estradiol 3-sulphate
bmse000642
cMAP_000005
cis-Estradiol
cis-Oestradiol
component of Menrium
delta-Estradiol
delta-Oestradiol
estradiol
estradiol-17beta
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
progynon
10
MegestrolPhase 4, Phase 3, Phase 2, Phase 1643562-63-819090, 3080587
Synonyms:
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione
3562-63-8
AC1L2DG3
C07120
CID19090
Chronopil
Chronopil (TN)
D008535
D08167
DB00351
 
EINECS 222-628-6
HSDB 3233
LS-118488
MGA
Megestrol (INN)
Megestrol Acetate
Megestrol [INN:BAN]
Megestrolo
Megestrolo [DCIT]
Megestrolum [INN-Latin]
Megestryl acetate
UNII-EA6LD1M70M
megestrol
11ProgestinsPhase 4, Phase 3, Phase 2, Phase 1, Phase 0525
12
LevonorgestrelPhase 4, Phase 3, Phase 2288797-63-7, 17489-40-613109
Synonyms:
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
(-)-Norgestrel
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one
)-Norgestrel
121714-72-5
13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE
13-Ehyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one
13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one
13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one
13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one
13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
17-Ethynyl-18-methyl-19-nortestosterone
17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one
17-alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17alpha-Ethynyl-18-homo-19-nor-testosterone
17alpha-Ethynyl-18-homo-19-nortestosterone
17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one
18,19-Dinor-4-pregnen-20-yn-3-one
18-Methyl-17-alpha-ethynyl-19-nortestosterone
18-Methylnorethisterone
4222-79-1
6533-00-2
72-HOURS
797-62-6
797-63-7
AC1L211U
AC1Q6OEV
BAY 86-5028
BAY86-5028
BIDD:PXR0194
BPBio1_000932
BRD-K35189033-001-03-0
BRN 2391114
BSPBio_000846
Bio-0595
C08149
C08153
CCRIS 6525
CCRIS 9033
CHEBI:44593
CHEBI:6443
CHEMBL1389
CID13109
CPD000059117
Capronor
D(−
D(-)-Norgestrel
D-(-)-Norgestrel
D-Norgestrel
D00950
D00954
DB00367
DB00506
E-Gen-C
EINECS 212-349-8
EINECS 229-433-5
FH 122-A
Follistrel
HMS1570K08
HMS2051M08
HMS2090O06
HSDB 3595
HSDB 6483
Jadelle
LD norgestrel [French]
LMST02030119
LO/Ovral
LS-62083
LS-62084
Ld norgestrel
Levlen
Levlen ED
Levonelle
Levonelle, D-Norgestrel, Levonova, Levonorgestrel
Levonorgestrel
Levonorgestrel (JAN/USP/INN)
Levonorgestrel [USAN:INN:BAN]
Levonorgestrel implants
Levonorgestrelum
Levonorgestrelum [INN-Latin]
Levonova
Levora-21
Levora-28
Logynon ED
Lévonorgestrel
MLS000069491
MLS000759484
 
MLS001074069
Methylnorethindrone
Microgest ED
Microgyn
Microgynon 21
Microgynon 28
Microgynon 30 ED
Microgynon CD
Microlut
Microlution
Microluton
Microval
Minivlar 30
Mirena
Mirena (TN)
MolPort-002-510-453
Monofeme 28
Monovar
N2260_FLUKA
N2260_SIGMA
NCGC00159349-02
NCGC00159349-03
NORPLANT
NSC744007
Neogest
Neogynon 21
NorLevo
Nordet
Nordette 21
Nordette 28
Norgeston
Norgestrel (JP15/USP/INN)
Norgestrel [Progestins]
Norgestrel [USAN:BAN:INN:JAN]
Norgestrel [USAN:INN:BAN:JAN]
Norgestrel-(-)-D
Norgestrelum
Norgestrelum [INN-Latin]
Norplant (TN)
Norplant 2
Norplant II
Norplant System in Plastic Container
Norplant-2
Ovoplex 30-150
Ovral-Lo
Ovranette
Ovrette
Ovrette (TN)
Plan B
Plan b
Postinor
Postinor-2
Prestwick0_000773
Prestwick1_000773
Prestwick2_000773
Prestwick3_000773
Prestwick_109
Preven
Rigevidon 21+7
S1727_Selleck
SAM001246694
SH 70850
SH 850
SMR000059117
SMR000653526
SOH-075
SPBio_002785
Stediril 30
Tetragynon
Tri-Levlen 21
Triagynon
Triciclor
Trifeme 28
Trigoa
Trinordiol 21
Trinordiol 28
Triphasil 21
Triphasil 28
Triquilar ED
Trivora
UNII-3J8Q1747Z2
UNII-5W7SIA7YZW
Wy 3707
Wy-3707
Wy-5104
ZINC03814395
alpha-Norgestrel
component of Lo/ovral
d(-)-Norgestrel
dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone
dl-Norgestrel
norgestrel
13
HydroxocobalaminPhase 423613422-51-011953898, 5460373, 44475014
Synonyms:
13422-51-0
22465-48-1
78091-12-0
8017-22-9
Acti-B12
AlphaRedisol
AlphaRedisol (TN)
Axion
Axlon
Benzimidazolyl ribofuranosyl phosphate deriv.
C08230
C62H85CoN13O15P
CHEBI:27786
CHEMBL1200742
CHEMBL235822
CID11622291
CID11953898
CID5460373
CID6433575
CID6474319
Ciplamin H
Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-hydroxocobamide
Cobalex
Cobalin H
Cobinamide dihydroxide dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Cobinamide, Co-hydroxy-, dihydrogen phosphate (ester), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono (inner salt), 3'- ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Codroxomin
Cyanokit
Cyanokit (TN)
D01027
DB00200
Depogamma
Docclan
Docelan
Docelvita
Docevita
Droxomin
Ducobee Hy
Ducobee-Hy
Duradoce
Duralta-12
EINECS 236-533-2
HSDB 3342
HYDROXOCOBALAMIN
Hidroxocobalamina
Hidroxocobalamina [INN-Spanish]
Hydro Cobex
 
Hydrobamine
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxocobalamin (JAN/USP/INN)
Hydroxocobalamin Vitamin B12
Hydroxocobalamin [USAN:INN:BAN:JAN]
Hydroxocobalamin acetate
Hydroxocobalamin anhydrous
Hydroxocobalamin monohydrochloride
Hydroxocobalamin(alkaline soln.), OH- replaces CN- in Cyanocobalamin)
Hydroxocobalaminacetat
Hydroxocobalamine
Hydroxocobalamine [INN-French]
Hydroxocobalaminum
Hydroxocobalaminum [INN-Latin]
Hydroxocobalaminum anhydrous
Hydroxocobemine
Hydroxomin
Hydroxy Cobal
Hydroxy vitamin B12
Hydroxycob(lll)alamin
Hydroxycobalamin
Hydroxycobalamine
Hyxobamine
Idrogrisevit
Idrossocobalamina
Idrossocobalamina [DCIT]
LS-54607
Lyovit-H
Neo-Betalin 12
Neo-cytamen
Neo-macrabin
Neo-rojamin
OH-Cbl
OH-Duphar
Ohb12
Oxobemin
Oxolamine (arcum)
Primabalt RP
Redisol-H
S1668_Selleck
Sytobex-H
UNII-Q40X8H422O
Vibeden
Vitadurin
Vitamin B(sub 12a)
Vitamin B-12b
Vitamin B12a
Vitamin B12b
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
vitamin B-12b
14glucocorticoidsPhase 4, Phase 2, Phase 14756
15CLOMIPHENEPhase 4, Phase 2, Phase 3, Phase 0161
16
Ethinyl EstradiolPhase 4, Phase 270457-63-65991
Synonyms:
17 alpha-Ethinylestradiol
17 alpha-Ethynylestradiol
17 alpha-Ethynyloestradiol
17 alpha-ethinyestradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17-alpha-Ethinyl-17-beta-estradiol
17-alpha-Ethynyl-17-beta-oestradiol
17-alpha-Ethynylestradiol
17-alpha-Ethynylestradiol-17-beta
17-alpha-ethynyl estradiol
17-ethinyl-3,17-estradiol
17-ethinyl-3,17-oestradiol
17-ethinylestradiol
17.alpha.-Ethinyl-17.beta.-estradiol
17.alpha.-Ethinylestradiol
17.alpha.-Ethynyl-17.beta.-oestradiol
17.alpha.-Ethynylestradiol
17.alpha.-Ethynylestradiol-l7.beta.
17.alpha.-Ethynyloestradiol
17.alpha.-Ethynyloestradiol-17.beta.
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol
17a-Ethynylestradiol-l7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17alpha-Ethinylestradiol
17alpha-Ethinylestradiol-17beta
17alpha-Ethynylestradiol
17alpha-Ethynyloestradiol
17alpha-Ethynyloestradiol-17beta
17α-ethynylestradiol
406932-93-2
46263_FLUKA
46263_RIEDEL
57-63-6
77538-56-8
AC-2169
AC1L1LK6
AI3-52941
Aethinyloestradiolum
Aethinyoestradiol
Aethinyoestradiol [German]
Alora
Amenoron
Amenorone
Anovlar
BIDD:ER0162
BRN 2419975
Bio-0610
C07534
CCRIS 286
CHEBI:4903
CHEMBL691
CID5991
CPD000058319
Certostat
Chee-O-Gen
Chee-O-Genf
Cyclosa
D004997
D00554
DB00977
Dicromil
Diognat-E
Diogyn E
Diogyn-E
Diprol
Dyloform
E4876_SIGMA
EE
EE(sub 2)
EE2
EINECS 200-342-2
EO
ETHINYLESTRADIOL
Effik Brand of Ethinyl Estradiol
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Estinyl (TN)
Eston-E
Estopherol
Estoral
Estoral (Orion)
Estoral (VAN)
Estoral [Orion]
Estoral {[Orion]}
Estorals
Estradiol, Ethinyl
Estradiol, Ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl E2
Ethinyl Estradiol Hemihydrate
Ethinyl Estradiol [USP]
 
Ethinyl Estradiol, (8 alpha)-Isomer
Ethinyl Oestradiol Effik
Ethinyl estradiol
Ethinyl estradiol (USP)
Ethinyl-Oestradiol Effik
Ethinyl-Oestranol
Ethinyl-oestranol
Ethinylestradiol
Ethinylestradiol (JP15/INN)
Ethinylestradiol Jenapharm
Ethinylestradiol [INN:BAN:JAN]
Ethinylestradiolum
Ethinylestradiolum [INN-Latin]
Ethinylestriol
Ethinyloestradiol
Ethinyloestradiol [Steroidal oestrogens]
Ethy 11
Ethynyl estradiol
Ethynylestradiol
Ethynylestradiol, Ethinyl Estradiol
Ethynyloestradiol
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
Etinilestradiol
Etinilestradiol [INN-Spanish]
Etinilestradiolo
Etinilestradiolo [DCIT]
Etinoestryl
Etistradiol
Etivex
Evra
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
HMS2051I19
HSDB 3587
Halodrin
Hemihydrate, Ethinyl Estradiol
Inestra
Innofem
Jenapharm Brand of Ethinyl Estradiol
Jenapharm, Ethinylestradiol
Kolpolyn
LMST02010036
LS-231
Linoral
Lynoral
MLS000028479
MLS000758274
Marvelon
Menolyn
Menostar
Mercilon
Microfollin
Microfollin Forte
MolPort-001-794-636
NCGC00091533-01
NCGC00091533-04
NCGC00091533-05
NCI60_000234
NSC-10973
NSC10973
Neo-Estrone
Nogest-S
Novestrol
OVULEN-21
OVULEN-28
Oradiol
Orestralyn
Orestrayln
Organon Brand of Ethinyl Estradiol
Ortho-Cyclen
Ovex
Oviol
PUBERTAL ETHINYL ESTRADIOL STUDY
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn M
Progynon C
Progynon M
Prosexol
S1625_Selleck
SAM001247008
SGCUT00127
SMR000058319
Schering Brand of Ethinyl Estradiol
Spanestrin
Thiuram E
Thiuranide
UNII-423D2T571U
Vagifem
Varnoline
WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ
Ylestrol
component of Demulen
component of Oracon
component of Ortrel
ethinyl estradiol
ethynyl estradiol
to_000048
17
MetforminPhase 4, Phase 3, Phase 2, Phase 1, Phase 01701657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
18
Citric AcidPhase 4, Phase 3, Phase 2, Phase 0106377-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
19
EnclomiphenePhase 4, Phase 2, Phase 3, Phase 016115690-57-0
Synonyms:
 
Clomiphene trans-form
20
MedroxyprogesteronePhase 4, Phase 3, Phase 2140520-85-410631
Synonyms:
(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
(6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione
17 alpha Hydroxy 6 alpha Methylprogesterone
17 alpha-Hydroxy-6 alpha-Methylprogesterone
17-Hydroxy-6.alpha.-methylprogesterone
17-Hydroxy-6a-methylprogesterone
17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6alpha-methylprogesterone
17.alpha.-Hydroxy-6.alpha.-methylprogesterone
17alpha-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione
17alpha-Hydroxy-6alpha-methylprogesterone
4-08-00-02211 (Beilstein Handbook Reference)
46411_FLUKA
46411_RIEDEL
520-85-4
6-Dihydromegestrol
6-alpha-Methyl-17-alpha-hydroxyprogesterone
6.alpha.-Methyl-17.alpha.-hydroxyprogesterone
6alpha-Methyl-17alpha-hydroxyprogesterone
6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione
6alpha-Methyl-5-pregnen-17alpha-ol-3,20-dione
AC-14528
AC1L1VM7
Adgyn Medro
Aragest
Aragest 5
Asconale
BRN 2510965
C07119
CBP-1011
CHEBI:6715
CHEMBL1390
CID10631
CPD000058769
Clinofem
Clinovir
Colirest
Cycrin
D008525
D08166
DB00603
DMPA
Depo-Clinovir
Depo-Prodasone
Depo-Progestin
Depo-Promone
Depo-Provera
Depo-Subq Provera 104
Depot-Medroxyprogesterone acetate
EINECS 208-298-6
Farlutal
Farlutal inyectable
Farlutal inyectable (TN)
Farlutin
G-Farlutal
Gestapuran
HMS2052A13
HSDB 3114
Hematrol
Hydroxymethylprogesterone
Hysron
 
Indivina
LMST02030176
LS-118713
Lunelle
Lutopolar
Lutoral
M6013_SIGMA
MAP
MLS000069571
MLS001076098
MPA Gyn 5
Med-Pro
Medroprogesterone Acetate
Medrossiprogesterone
Medrossiprogesterone [DCIT]
Medrossiprogesterone [Dcit]
Medroxiprogesterona
Medroxiprogesterona [INN-Spanish]
Medroxiprogesteronum
Medroxyprogesteron
Medroxyprogesteron acetate
Medroxyprogesterone (INN)
Medroxyprogesterone Acetate
Medroxyprogesterone Strakan Brand
Medroxyprogesterone [INN:BAN]
Medroxyprogesteronum
Medroxyprogesteronum [INN-Latin]
Meprate
Methylhydroxyprogesterone
Metigestrona
MolPort-005-934-866
NCGC00023064-04
NSC 27408
NSC27408
Nadigest
Nidaxin
Novo-Medrone
Oragest
Perlutex
Perlutex Leo
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6-alpha)- (9CI)
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)- (9CI)
Prodasone
Progestalfa
Progevera
Provera
Proverone
Ralovera
Repromap
Repromix
SAM001246906
SMR000058769
ST082267
Sirprogen
Sodelut G
Strakan Brand of Medroxyprogesterone
U 8840
UNII-HSU1C9YRES
Veramix
ZINC05763835
g-Farlutal
medroxyprogesterone
21
Medroxyprogesterone acetatePhase 4, Phase 3, Phase 214071-58-9
Synonyms:
(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
17-Acetoxy-6alpha-methylprogesterone
17-Acetoxy-6α-methylprogesterone
17alpha-Hydroxy-6alpha-methylprogesterone acetate
17α-hydroxy-6α-methylprogesterone acetate
6-alpha-Methyl-17-alpha-acetoxyprogesterone
6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate
6alpha-Methyl-17-acetoxy progesterone
 
6alpha-Methyl-17alpha-hydroxyprogesterone acetate
6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate
6α-Methyl-17-acetoxy progesterone
6α-Methyl-17α-hydroxyprogesterone acetate
MPA
Medroxyacetate progesterone
Medroxyprogesterone 17-acetate
Medroxyprogesterone acetate
Methylacetoxyprogesterone
Metigestrona
22Estradiol valeratePhase 4, Phase 2, Phase 3, Phase 01250979-32-8
23
LeuprolidePhase 428453714-56-03911, 657181
Synonyms:
(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone
5-oxoPro-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-ProNHC2H5 dihydrate
5-oxoprolylhistidyltryptophylseryltyrosylleucylleucyl-n5-(diaminomethylidene)ornithyl-n-ethylprolinamide
AC1L1GZK
AC1L9B44
AC1Q5OPO
AR-1G9354
C07612
CID3911
CID441410
D00989
D08113
Enantone
Enantone (TN)
I04-0109
L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide
L001094
 
L002030
Leuprolide
Leuprolide acetate
Leuprolide acetate (USAN)
Leuprorelin
Leuprorelin (INN)
Leuprorelin acetate (JAN)
Leuprorelina
Leuproreline
Leuprorelinum
Lupron (TN)
N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
NSC377526
NSC746847
PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5
PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet
acetic acid
leuprolide
24
PrednisolonePhase 4111850-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
25PREDNISOLONE ACETATEPhase 41118
26
MethylprednisolonePhase 4111883-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
27
Cyproterone acetatePhase 440427-51-0
Synonyms:
 
Cyproterone 17-O-acetate
28
ToremifenePhase 42689778-26-73005573
Synonyms:
(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)-N,N-dimethyl-ethylamine citrate(1:1)
2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine (IUPAC)
2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine
2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
89778-26-7
89778-27-8 (citrate (1:1))
98644-21-4
AC-1751
AC1MHJ33
Acapodene
BIDD:ER0222
BIDD:GT0211
BIDD:PXR0202
C08166
CCRIS 8745
CHEBI:9635
CHEMBL1655
CID3005573
D08620
DB00539
 
Estrimex
FC-1157a
Farestone
GTX-006 (Acapodene)
GTx 006
GTx-006
HMS2090B22
LS-7729
MolPort-002-508-208
NCGC00160530-01
STK626445
STOCK6S-27411
Toremifene (INN)
Toremifene Base
Toremifene Citrate (1:1)
Toremifene [INN:BAN]
Toremifeno
Toremifeno [Spanish]
Toremifenum
Toremifenum [Latin]
UNII-7NFE54O27T
Z-Toremifene
toremifene
{2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine
29
CyproteronePhase 4402098-66-05284537
Synonyms:
(1R,3aS,3bR,7aR,8aS,8bS,8cS,10aS)-1-acetyl-5-chloro-1-hydroxy-8b,10a-dimethyl-2,3,3a,3b,7a,8,8a,8b,8c,9,10,10a-dodecahydrocyclopenta[a]cyclopropa[g]phenanthren-7(1H)-one
2098-66-0
6-Chlor-delta(6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteron
6-Chlor-delta(sup 6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteron
6-Chlor-delta(sup 6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteron [German]
6-chloro-17-hydroxy-1beta,2beta-dihydro-3'H-cyclopropa[1,2]pregna-4,6-diene-3,20-dione
AC-6213
AC1L1EZB
AC1L27WO
Apo-cyproterone
BAY 94-8367
BAY94-8367
BSPBio_003462
C22H27ClO3
CHEBI:50742
CHEMBL142130
CID10044976
CID16417
CID3015
CID5284537
CID5702275
Ciproterona
Ciproterona Servycal
Ciproterona Servycal (TN)
Ciproterona [INN-Spanish]
Ciproterone
Ciproterone [DCIT]
CyPat
Cyproteron
Cyproterone (INN)
Cyproterone [INN:BAN]
 
Cyproterone acetate
Cyproteronum
Cyproteronum [INN-Latin]
D07766
DB04839
DivK1c_000786
Gen-Cyproterone
HMS1922K16
HMS502H08
IDI1_000786
KBio1_000786
KBio2_002052
KBio2_004620
KBio2_007188
KBio3_002966
KBioGR_001485
KBioSS_002052
LS-58798
MolPort-003-981-177
MolPort-005-932-862
NCGC00178048-01
NINDS_000786
Novo-cyproterone
SH 80881
SPBio_001594
SPECTRUM1503921
Spectrum2_001597
Spectrum3_001901
Spectrum4_000853
Spectrum5_001362
Spectrum_001572
UNII-E61Q31EK2F
cyproterone
30taxanePhase 4, Phase 3, Phase 1335
31
Nandrolone decanoatePhase 429360-70-39677
Synonyms:
19-nortestosterone decanoate
Deca-durabolin
 
Nandrolone 17β-decanoate
Norandrostenolone decanoate
Nortestosterone decanoate
32DienogestPhase 44065928-58-7
33
NandrolonePhase 429434-22-09904, 229455
Synonyms:
(17-beta)-17-Hydroxyestr-4-en-3-one
(17beta)-17-hydroxyestr-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
17-Hydroxy-Estr-4-Ene-3-One
17-beta-Hydroestr-4-en-3-one
17beta-Hydroxy-19-nor-4-androsten-3-one
17beta-Hydroxy-19-norandrost-4-en-3-one
17beta-Hydroxy-4-estren-3-one
17beta-hydroxyestr-4-en-3-one
19-Norandrostenolone
19-Nortestosterone
19NTPP
4-Estren-17beta-ol-3-one
434-22-0
46476_FLUKA
46476_RIEDEL
74640_ALDRICH
74640_FLUKA
AC-15207
AC1L1U32
C07254
C18H26O2
CHEBI:7466
CHEMBL757
CID9904
CPD000058610
D08250
Deca-Durabolin
Durabolin
EINECS 207-101-0
Estr-4-en-3-one, 17-hydroxy-, (17-beta)- (9CI)
Estr-4-en-3-one, 17-hydroxy-, (17beta)- (9CI)
Estr-4-en-3-one, 17beta-hydroxy- (8CI)
Estrenolone
HMS2051I04
HSDB 3368
LMST02010044
LS-64851
LT03330030
MLS002222325
 
Menidrabol
MolPort-003-849-312
N7252_SIGMA
NCGC00159416-02
NPP
NSC 3351
NTPP
Nadrolone
Nadrolone phenylpropionate
Nandrolin
Nandrolon
Nandrolon phenylpropionate
Nandrolona
Nandrolona [INN-Spanish]
Nandrolone (INN)
Nandrolone Base
Nandrolone Decanoate
Nandrolone Decanoic acid
Nandrolone Phenpropionate
Nandrolone phenpropionate
Nandrolone phenylpionate
Nandrolone phenylpropionate
Nandrolonum
Nandrolonum [INN-Latin]
Norandrolone phenyl propionate
Norandrostenolon
Norandrostenolone
Norandrostenolone phenylpropionate
Nortestonate
Nortestosterone
Nortestosterone phenylpropionate
Nortestosteronum
Oestrenolon
SAM001246751
SMR000058610
Testosterone phenylpropionate
U 2410
UNII-6PG9VR430D
ZINC03814379
decadura
decadura (TN)
nandrolone
34
Folic AcidNutraceuticalPhase 4, Phase 3, Phase 2, Phase 1414359-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
35CitrateNutraceuticalPhase 4, Phase 3, Phase 2, Phase 01063
36
MethylcobalaminNutraceuticalPhase 423713422-55-4
Synonyms:
Algobaz
Co-Methylcobalamin
Co-methylcobalamin
Hitocobamin M
MeCbl
Mecobalamin
Methycobal
 
Methyl cobalamine
Methyl vitamin B12
Methyl-5,6-dimethylbenzimidazolylcobalamin
Methyl-B12
Methylcob(III)alamin
Methylcobalamin
Methylcobaz
mecobalamin
methyl(III)cobalamin
37
CyanocobalaminNutraceuticalPhase 423768-19-944176380
Synonyms:
Anacobin
Bedoz
Berocca PN
Berubigen
Betalin 12
Betalin 12 Crystalline
Betaline-12
Betolvex
Bevidox
Bevidox concentrate
Biocobalamine
Byladoce
Cabadon m
Cernevit-12
Cobadoce forte
Cobalin
Cobavite
Cobex
Cobolin-M
Copharvit 5000
Covit
Crystamin
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-B12
Cyanobalamin concentrate
Cyanocob(III)alamin
Cyanocobalamin (JP15/USP)
Cyanocobalamin Co 57 Schilling Test Kit
Cyanocobalamine
Cyanocobalmin
Cyanoject
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dicopac Kit
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
Duodecibin
Embiol
Emociclina
Eritrone
Erycytol
 
Erythrotin
Euhaemon
Extrinsic factor
Factor II
Fermin
Fresmin
Hemomin
Hepagon
Hepavis
Hepcovite
Hylugel plus
Infuvite Pediatric
Lactobacillus lactis dorner factor
M.V.I. Pediatric
Macrabin
Megabion
Megalovel
Milbedoce
Millevit
Nagravon
Nascobal
Nascobal (TN)
Neuroforte-R
Normocytin
Novidroxin
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
Rubivite
Rubramin
Rubramin PC
Rubratope-57 Kit
Rubratope-60 Kit
Rubripca
Rubrocitol
Ruvite
Shovite
Sytobex
Vi-Twel
Vibal
Vibalt
Vibisone
Virubra
Vita-rubra
Vitabee 12
Vitamin B12
Vitamin B12 Preparation
Vitamin B12 complex
Vitaped
Vitarubin
Vitral
vitamine b12
38InositolNutraceuticalPhase 482
39Vitamin B12NutraceuticalPhase 4237
40FolateNutraceuticalPhase 4, Phase 3, Phase 2, Phase 14143
41
cobalaminNutraceuticalPhase 423713408-78-16438156
Synonyms:
5,6-Dimethyl-1-a-D-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-a-D-ribofuranosylbenzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosylbenzimidazole
Cob(III)alamin
Cobalamin (III)
Cobalamine
 
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
Hydroxomin
Rubivite
Rubratope-57
Rubratope-60
Ruvite
Vitamin B12
42
MelatoninNutraceuticalPhase 424573-31-4896
Synonyms:
0E2B08C1-B325-45B1-8939-6F9081EFDFA4
4-ACETAMIDO-4'-ISOTHIO-CYANATOSTILBENE-2,2'-DISULFONIC ACID
5-22-12-00042 (Beilstein Handbook Reference)
5-Methoxy-N-acetyltryptamine
5-methoxy-N-acetyltryptamine
73-31-4
A4039/0172195
AB00053279
AC1L1A9Q
AC1Q4F1W
AC1Q4F1X
AKOS000276269
Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)- (9CI)
Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI)
Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI)
Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}
Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}
BAS 01281092
BIDD:ER0618
BPBio1_000590
BRD-K97530723-001-07-6
BRN 0205542
BSPBio_000536
BSPBio_003006
Bio-0635
C01598
CAS-73-31-4
CCRIS 3472
CHEBI:16796
CHEMBL45
CID896
ChemDiv2_003916
Circadin
D008550
D08170
DB01065
DB08189
DivK1c_000353
EINECS 200-797-7
EU-0100787
HMS1380B22
HMS1569K18
HMS1921E04
HMS2089F09
HMS501B15
HSCI1_000400
HSDB 7509
I05-0076
I10-0345
IDI1_000353
IDI1_002631
IN1244
KBio1_000353
KBio2_000665
KBio2_003233
KBio2_005801
KBio3_002226
KBioGR_000591
KBioSS_000665
L001261
LS-1623
Lopac-M-5250
Lopac0_000787
M 5250
M-1200
M-1250
M1105
M5250_SIGMA
ML1
MLS000859594
MLS001055382
MLS001240204
MT6
Mela-T
Melapure
Melatol
Melatonex
Melatonex, Melatonin
Melatonin
Melatonin (synth.) standard-grade
 
Melatonin (synth.) ultra-pure
Melatonina
Melatonina (TN)
Melatonine
Melovine
MolPort-000-737-883
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)-Acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
N-Acetyl-5-methoxy-tryptamine
N-Acetyl-5-methoxy-tryptamine Melatonine
N-Acetyl-5-methoxytryptamine
N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-Acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]-Acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide
N-[2-(5-methoxyindol-3-yl)ethyl]acetamide
N-acetyl-5-methoxy-tryptamine
NCGC00015680-01
NCGC00015680-02
NCGC00015680-03
NCGC00015680-06
NCGC00015680-13
NCGC00090727-01
NCGC00090727-02
NCGC00090727-03
NCGC00090727-04
NCGC00090727-05
NCGC00090727-06
NCGC00090727-07
NCGC00090727-08
NCGC00090727-09
NCI60_004378
NINDS_000353
NMR/14327425
NSC 113928
NSC113928
NSC56423
Nature'S Harmony
Night Rest
Oprea1_104553
Oprea1_814234
PREVENTION 1 (MELATONIN) (PREVENTION 1)
PREVENTION 2 (MELATONIN)
PREVENTION 3 (MELATONIN)
PREVENTION 4 (MELATONIN)
PREVENTION 5 (MELATONIN)
Pineal Hormone
Posidorm
Prestwick0_000458
Prestwick1_000458
Prestwick2_000458
Prestwick3_000458
Prestwick_312
Regulin
Revital Melatonin
Rx Balance
S1204_Selleck
SDCCGMLS-0065812.P001
SDCCGMLS-0065812.P002
SMP2_000309
SMR000326666
SPBio_001527
SPBio_002475
SPECTRUM1500690
STK386880
Sleep Right
Spectrum2_001344
Spectrum3_001393
Spectrum4_000066
Spectrum5_001745
Spectrum_000185
TNP00300
UNII-JL5DK93RCL
Vivitas
WLN: T56 BMJ D2MV1 GO1
ZINC00057060
{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetamide
{N-[2-(5-methoxyindol-3-yl)ethyl]-} Acetamide
43tannic acidNutraceuticalPhase 4, Phase 21794
44
DocetaxelApproved May 1996Phase 3, Phase 1, Phase 21880114977-28-5148124, 9877265
Synonyms:
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate
(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
01885_FLUKA
114977-28-5
4-(Acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
AC-383
AC1L3WHJ
ANX-514
BIND-014
C11231
CHEBI:4672
CHEMBL92
CID148124
D07866
DB01248
Docetaxel
Docetaxel (INN)
Docetaxel anhydrous
Docetaxel, Trihydrate
EmDOC
 
HMS2089K08
InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,5
MolPort-003-847-005
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-Boc-10-deacetyl taxol
NSC-628503
PSMA-targeted docetaxel nanoparticle
RP-56976
SDP-014
TXL
Taxotere
Taxotere (TN)
Taxotere(R)
XRP-6976L
docetaxel
docetaxel 114977-28-5
nchembio.188-comp8
nchembio.2007.34-comp7
nchembio.573-comp11
nchembio853-comp8
45
DoxilApproved June 1999Phase 3, Phase 2, Phase 1167631703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
46topoisomerase I inhibitorsPhase 2, Phase 3, Phase 11313
47
TopotecanPhase 2, Phase 3, Phase 1336119413-54-6, 123948-87-860700
Synonyms:
(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE
(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione
(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
123948-87-8
9-Dimethylaminomethyl-10-hydroxycamptothecin
9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin
AC-11592
AC1L1TQZ
AC1Q6APZ
BSPBio_002348
C11158
C23H23N3O5
CCRIS 8163
CHEBI:107501
CHEBI:46035
CHEMBL84
CID60700
D08618
DB01030
HMS2090B20
HSCI1_000228
Hycamptamine
Hycamptin
Hycamtamine
Hycamtin
Hycamtin (TN)
LS-127395
 
MLS000759456
NCGC00178695-01
NCI60_004771
NCIStruc1_001659
NCIStruc2_001796
NChemBio.2007.10-comp24
NSC609699
SK&F-104864-A
SKF 104864
SKF-104864-A
SKF-S 104864
SMP2_000312
SMP2_000327
SMR000466344
TOPO
TOPOTECAN, HYCAMTIN
TPT
TTC
Topotecan (BAN)
Topotecan Hcl
Topotecan Hydrochloride
Topotecan Lactone
Topotecan Monohydrochloride, (S)-Isomer
Topotecan [INN:BAN]
Topotecan lactone
Topotecane
Topotecane [INN-French]
Topotecanum
Topotecanum [INN-Latin]
UNII-7M7YKX2N15
topotecan
48
Maleic acidPhase 2, Phase 3, Phase 1292110-16-7444266
Synonyms:
(2Z)-2-Butenedioate
(2Z)-2-Butenedioic acid
(2Z)-Butene-2-dioate
(2Z)-Butene-2-dioic acid
(2Z)-but-2-enedioate
(2Z)-but-2-enedioic acid
(Z)-2-Butenedioate
(Z)-2-Butenedioic acid
(z)-butenedioate
(z)-butenedioic acid
2-Butenedioate
2-Butenedioic acid
Cis-butenedioate
Cis-butenedioic acid
 
H2male
Kyselina maleinova
MAE
Maleate
Maleic acid
Maleic acid [NA2215]
Maleinic acid
Malenic acid
Malezid CM
Scotchbond multipurpose etchant
Toxilic acid
cis-1,2-Ethylenedicarboxylic acid
cis-2-Butenedioate
cis-2-Butenedioic acid
cis-But-2-enedioate
cis-But-2-enedioic acid
49
DydrogesteronePhase 2, Phase 320152-62-59051
Synonyms:
(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
(9-beta,10-alpha)-Pregna-4,6-diene-3,20-dione
(9beta,10alpha)-pregna-4,6-diene-3,20-dione
(9β,10α)-pregna-4,6-diene-3,20-dione
.DELTA.6-Retroprogesterone
10alpha-Isopregnenone
152-62-5
6 Dehydro 9 beta 10 alpha progesterone
6-Dehydro-9 beta-10 alpha-progesterone
6-Dehydro-9.beta.,10.alpha.-progesterone
6-Dehydro-9beta,10alpha-progesterone
6-Dehydro-retro-progesterone
6-Dehydroretroprogesterone
9-.beta.,10.alpha.-Pregna-4,6-diene-3,20-dione
9-beta,10-alpha-Pregna-4,6-diene-3,20-dione
9-beta,10alpha-Pregna-4,6-diene-3,20-dione
9.beta.,10.alpha.-Pregna-4,6-diene-3,20-dione
9beta,10alpha-Pregna-4,6-diene-3,20-dione
9beta,10alpha-Pregna-4,6-diene-3,20-dione (8CI)
9β,10α-pregna-4,6-diene-3,20-dione
AB00513884
AC1L1S7M
BPBio1_000839
BRD-K68620903-001-03-1
BSPBio_000761
CCRIS 9069
CHEBI:31527
CHEMBL1200853
CID9051
D004394
D01217
DB00378
Dehydrogesterone
Didrogesterona
Didrogesterone
Didrogesterone [DCIT]
Diphaston
Dufaston
Duphaston
Duphaston (TN)
Duvaron
 
Dydrogesterona
Dydrogesterona [INN-Spanish]
Dydrogesterone
Dydrogesterone (JP15/USP/INN)
Dydrogesterone [USAN:INN:BAN:JAN]
Dydrogesteronum
Dydrogesteronum [INN-Latin]
Dydrogestérone
EINECS 205-806-8
Gestatron
Gynorest
Gynorest (TN)
HMS1570G03
HSDB 3321
Hydrogesterone
Hydrogestrone
I06-1088
Isopregnenone
LS-118418
MLS002153947
MolPort-005-940-416
NCGC00179445-01
NSC 92336
NSC92336
Pregna-4,6-diene-3,20-dione, (9-beta,10-alpha)- (9CI)
Prestwick0_000671
Prestwick1_000671
Prestwick2_000671
Prestwick3_000671
Prodel
Retro-6-dehydroprogesterone
Retrone
SMR001233286
SPBio_002682
Solvay Brand of Dydrogesterone
Terolut
UNII-90I02KLE8K
ZINC03875998
delta(6)-Retroprogesterone
delta(Sup 6)-retroprogesterone
delta(sup 6)-Retroprogesterone
didrogesterona
dydrogesterone
50pancreatic polypeptidePhase 3, Phase 120

Interventional clinical trials:

(show top 50)    (show all 789)
idNameStatusNCT IDPhase
1A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue TreatmentCompletedNCT00190697Phase 4
2Apoptotic Signaling Pathways in Rats With Endometrial HyperplasiaCompletedNCT02872818Phase 4
3The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine InseminationCompletedNCT01219101Phase 4
4Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOSCompletedNCT02352597Phase 4
5Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound ParametersCompletedNCT01514942Phase 4
6Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal WomenCompletedNCT01048606Phase 4
7Effect of Hormone Replacement Therapy on Lupus ActivityCompletedNCT00392093Phase 4
8Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian SyndromeCompletedNCT01540747Phase 4
9Biomarker Guided Treatment in Gynaecological CancerRecruitingNCT02543710Phase 4
10Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic SurgeryRecruitingNCT00719017Phase 4
11Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast CancerRecruitingNCT02344940Phase 4
12Influence of Gum Chewing on Postoperative Bowel Activity After Complete Staging Surgery for Gynecological MalignanciesRecruitingNCT01835119Phase 4
13Endometrial Scratching During Laproscopic Ovarian Drilling in Subfertile PCOS WomenRecruitingNCT02140398Phase 4
14HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS PatientsRecruitingNCT02273791Phase 4
15Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine LeiomyomaRecruitingNCT02361879Phase 4
16Adding Prednisolone During Ovulation Induction With CC in Lean Women With CC Resistant PCOSRecruitingNCT02344888Phase 4
17Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOSRecruitingNCT02436226Phase 4
18The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOSRecruitingNCT02866786Phase 4
19Letrozole Versus Clomifene Citrate for Ovulation InductionRecruitingNCT00478504Phase 4
20A Study Comparing Mirena and Systemic Progestin for Endometrial HyperplasiaActive, not recruitingNCT01074892Phase 4
21Endometrial Preparation Before Operative Hysteroscopy in Premenopausal WomenNot yet recruitingNCT02440750Phase 4
22IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF FailureNot yet recruitingNCT02601196Phase 4
23Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene CitrateWithdrawnNCT01966575Phase 4
24Pharmacokinetics and Safety of Transdermal Megestrol AcetateWithdrawnNCT00163072Phase 4
25Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00262847Phase 3
26Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00006011Phase 3
27Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial CancerCompletedNCT00002568Phase 3
28Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian CancerCompletedNCT00003322Phase 3
29Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00002717Phase 3
30Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian CancerCompletedNCT00003644Phase 3
31Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00483782Phase 3
32An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationCompletedNCT00132704Phase 3
33S9630, Medroxyprogesterone in Treating Women With Breast CancerCompletedNCT00002920Phase 3
34Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerCompletedNCT00002493Phase 3
35Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial CancerCompletedNCT00006027Phase 3
36Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for CancerCompletedNCT00245050Phase 3
37Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00003691Phase 3
38Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial CancerCompletedNCT00005583Phase 3
39Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial CancerCompletedNCT00003749Phase 3
40Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone SurgeryCompletedNCT00002807Phase 3
41Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal CancerCompletedNCT00003267Phase 3
42External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial CancerCompletedNCT00376844Phase 3
43Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the UterusCompletedNCT00002459Phase 3
44Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaCompletedNCT00002764Phase 3
45Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaCompletedNCT00002641Phase 3
46Tachosil for the Prevention of Symptomatic Lymph CystsCompletedNCT01470677Phase 3
47Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the PelvisCompletedNCT00033605Phase 3
48Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the UterusCompletedNCT00002706Phase 3
49ATAC - Endometrial Sub-ProtocolCompletedNCT00814125Phase 3
50Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast CancerCompletedNCT00038467Phase 3

Search NIH Clinical Center for Endometrial Cancer


Cochrane evidence based reviews: carcinoma, endometrioid

Genetic Tests for Endometrial Cancer

About this section

Genetic tests related to Endometrial Cancer:

id Genetic test Affiliating Genes
1 Endometrial Carcinoma25
2 Endometrial Neoplasm25
3 Endometrial Carcinoma, Somatic23 MSH3

Anatomical Context for Endometrial Cancer

About this section

MalaCards organs/tissues related to Endometrial Cancer:

34
Breast, Uterus, Lymph node, Ovary, Testes, Endothelial, Colon

FMA organs/tissues related to Endometrial Cancer:

17
The tissue lining the uterus

Animal Models for Endometrial Cancer or affiliated genes

About this section

MGI Mouse Phenotypes related to Endometrial Cancer:

39 (show all 33)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000118610.8CTNNB1, EGFR, FGFR2, KRAS, PTEN, TP53
2MP:000537710.8CTNNB1, EGFR, ESR2, FGFR2, KRAS, TP53
3MP:000538210.7CCND1, CTNNB1, EGFR, ERBB2, FGFR2, KRAS
4MP:000537010.7CTNNB1, EGFR, ESR1, ESR2, FGFR2, KRAS
5MP:000537510.5EGFR, ESR1, ESR2, FGFR2, PIK3CA, PTEN
6MP:000301210.5CDH1, CTNNB1, EGFR, ESR1, ESR2, FGFR2
7MP:000538810.5CCND1, CTNNB1, EGFR, ERBB2, ESR1, ESR2
8MP:000538010.4CDH1, CTNNB1, EGFR, ERBB2, ESR1, FGFR2
9MP:000536910.4CTNNB1, EGFR, ERBB2, ESR1, ESR2, FGFR2
10MP:000539710.4CCND1, CTNNB1, EGFR, ESR1, ESR2, FGFR2
11MP:000538710.4CCND1, CDH1, CTNNB1, EGF, EGFR, ESR1
12MP:001077110.4CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
13MP:000538910.3CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
14MP:000536710.3CTNNB1, EGFR, ESR1, ESR2, FGFR2, KRAS
15MP:000538110.3CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
16MP:000538410.3CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1
17MP:000200610.2CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1
18MP:000363110.2CCND1, CTNNB1, EGFR, ERBB2, ESR1, ESR2
19MP:000539110.2CCND1, CTNNB1, EGF, EGFR, FGFR2, KRAS
20MP:000287310.2CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
21MP:000538510.2CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1
22MP:001076810.1CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1
23MP:000537910.0CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
24MP:000537810.0CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
25MP:000538610.0CCND1, CTNNB1, ERBB2, ESR1, ESR2, FGFR2
26MP:000539010.0CCND1, CTNNB1, EGFR, ERBB2, ESR1, ESR2
27MP:00053719.8CTNNB1, EGFR, ERBB2, ESR1, ESR2, FGFR2
28MP:00053769.7CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1

Publications for Endometrial Cancer

About this section

Articles related to Endometrial Cancer:

(show top 50)    (show all 1356)
idTitleAuthorsYear
1
In reply to Binder et al "Adult Comorbidity Evaluation 27 Score in Endometrial Cancer Patient". (27640945)
2016
2
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer. (25878334)
2015
3
Association of the +331G/A progesterone receptor gene (PgR) polymorphism with risk of endometrial cancer in Caucasian women: a meta-analysis. (25037596)
2015
4
HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant. (25602714)
2015
5
CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer. (25281766)
2014
6
The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer. (24651628)
2014
7
Switch in FOXA1 status associates with endometrial cancer progression. (24849812)
2014
8
Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer. (25001096)
2014
9
Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer. (24997474)
2014
10
Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer. (25610319)
2014
11
Genome-wide association study of endometrial cancer in E2C2. (24096698)
2014
12
ZEB1 expression in endometrial biopsy predicts lymph node metastases in patient with endometrial cancer. (25544793)
2014
13
Methylation of the HOXA10 homeobox gene promoter is associated with endometrial cancer: a pilot study. (23815210)
2013
14
The effect of cadmium on the coagulation and fibrinolytic system in women with uterine endometrial cancer and myoma. (23690264)
2013
15
HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival. (24252907)
2013
16
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. (22037318)
2012
17
GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer. (22543280)
2012
18
KCC1 gene advances cell invasion ability by regulating ERK signaling pathway in endometrial cancer HEC-1B cell line. (21666489)
2011
19
Testing women with endometrial cancer to detect Lynch syndrome. (21537049)
2011
20
Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer. (20082853)
2010
21
Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer. (20638839)
2010
22
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. (19396818)
2009
23
Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival. (19319135)
2009
24
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. (19124504)
2009
25
Selective gene transfer to endometrial cancer cells by a polymer against matrix metalloproteinase 2 (MMP-2). (18454694)
2008
26
A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer. (18348659)
2008
27
Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. (17285578)
2007
28
Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation]. (17697604)
2007
29
p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells. (17636407)
2007
30
The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer. (17167982)
2006
31
Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR. (16683245)
2006
32
Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines. (15866122)
2005
33
Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States). (15280642)
2004
34
Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. (15016316)
2004
35
Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells. (15458748)
2004
36
Arzoxifene as therapy for endometrial cancer. (12928005)
2003
37
Expression and potential roles of pregnane X receptor in endometrial cancer. (12970323)
2003
38
Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. (12631221)
2003
39
Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia. (12111402)
2002
40
High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer. (11774293)
2002
41
Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance. (11263931)
2001
42
Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer. (11056312)
2000
43
Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer. (10831349)
2000
44
Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer. (11078809)
2000
45
Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. (11268488)
2000
46
Epidermal growth factor activates protein kinase C in the human endometrial cancer cell line HEC-1-A. (9345355)
1997
47
Multiple isoforms of the oestrogen receptor in endometrial cancer. (7669226)
1995
48
Expression of sex hormone-binding globulin mRNA in human endometrial cancers. (7779755)
1995
49
Expression of aberrant estrogen receptor mRNA in endometrial cancers in comparison with normal endometria. (7995615)
1994
50
Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer]. (8508979)
1993

Variations for Endometrial Cancer

About this section

UniProtKB/Swiss-Prot genetic disease variations for Endometrial Cancer:

68
id Symbol AA change Variation ID SNP ID
1PTENp.His123TyrVAR_026260rs786204931

Clinvar genetic disease variations for Endometrial Cancer:

5 (show all 12)
id Gene Variation Type Significance SNP ID Assembly Location
1CDH1NM_004360.4(CDH1): c.2131C> G (p.Leu711Val)single nucleotide variantPathogenicrs121964871GRCh37Chr 16, 68857496: 68857496
2KRASNM_033360.3(KRAS): c.34G> T (p.Gly12Cys)single nucleotide variantPathogenicrs121913530GRCh37Chr 12, 25398285: 25398285
3KRASNM_004985.4(KRAS): c.40G> A (p.Val14Ile)single nucleotide variantPathogenicrs104894365GRCh37Chr 12, 25398279: 25398279
4FGFR2NM_022970.3(FGFR2): c.755C> G (p.Ser252Trp)single nucleotide variantPathogenicrs79184941GRCh37Chr 10, 123279677: 123279677
5FGFR2NM_000141.4(FGFR2): c.1124A> G (p.Tyr375Cys)single nucleotide variantPathogenicrs121913478GRCh37Chr 10, 123274794: 123274794
6MUTYHNM_001128425.1(MUTYH): c.536A> G (p.Tyr179Cys)single nucleotide variantPathogenicrs34612342GRCh37Chr 1, 45798475: 45798475
7MUTYHNM_001128425.1(MUTYH): c.1187G> A (p.Gly396Asp)single nucleotide variantPathogenicrs36053993GRCh37Chr 1, 45797228: 45797228
8MLH3NM_001040108.1(MLH3): c.2221G> T (p.Val741Phe)single nucleotide variantPathogenicrs28756990GRCh37Chr 14, 75514138: 75514138
9MLH3MLH3, 1-BP DEL, 885GdeletionPathogenic
10PTENNM_000314.6(PTEN): c.253+1G> Asingle nucleotide variantPathogenicrs587776667GRCh37Chr 10, 89690847: 89690847
11MSH3NM_002439.4(MSH3): c.1148delA (p.Lys383Argfs)deletionPathogenicrs587776701GRCh38Chr 5, 80675103: 80675103
12MSH6NM_000179.2(MSH6): c.2731C> T (p.Arg911Ter)single nucleotide variantPathogenicrs63751017GRCh37Chr 2, 48027853: 48027853

Cosmic variations for Endometrial Cancer:

8 (show top 50)    (show all 598)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1COSM5219PTENendometrium,NS,carcinoma,endometrioid carcinomac.388C>Gp.R130G0
2COSM6147PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.1636C>Gp.Q546E0
3COSM516KRASendometrium,NS,carcinoma,endometrioid carcinomac.34G>Tp.G12C0
4COSM532KRASendometrium,NS,carcinoma,endometrioid carcinomac.38G>Ap.G13D0
5COSM10656TP53endometrium,NS,carcinoma,endometrioid carcinomac.742C>Tp.R248W0
6COSM86041PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.278G>Ap.R93Q0
7COSM184236ARID1Aendometrium,NS,carcinoma,endometrioid carcinomac.2077C>Tp.R693*0
8COSM5347003ARID1Aendometrium,NS,carcinoma,endometrioid carcinomac.5299G>Tp.E1767*0
9COSM5676CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.122C>Tp.T41I0
10COSM761PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.1625A>Gp.E542G0
11COSM5144PTENendometrium,NS,carcinoma,endometrioid carcinomac.464A>Gp.Y155C0
12COSM36903FGFR2endometrium,NS,carcinoma,endometrioid carcinomac.755C>Gp.S252W0
13COSM5682CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.97T>Cp.S33P0
14COSM5347088CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.634C>Tp.R212C0
15COSM5078PTENendometrium,NS,carcinoma,endometrioid carcinomac.367C>Tp.H123Y0
16COSM5286PTENendometrium,NS,carcinoma,endometrioid carcinomac.752G>Tp.G251V0
17COSM3970361TP53endometrium,NS,carcinoma,endometrioid carcinomac.472C>Ap.R158S0
18COSM10808TP53endometrium,NS,carcinoma,endometrioid carcinomac.488A>Gp.Y163C0
19COSM763PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.1633G>Ap.E545K0
20COSM5687CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.109T>Cp.S37P0
21COSM5251PTENendometrium,NS,carcinoma,endometrioid carcinomac.200T>Gp.I67R0
22COSM249834PTENendometrium,NS,carcinoma,endometrioid carcinomac.635-2A>Gp.?0
23COSM5277PTENendometrium,NS,carcinoma,endometrioid carcinomac.389G>Cp.R130P0
24COSM5662CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.110C>Tp.S37F0
25COSM5154PTENendometrium,NS,carcinoma,endometrioid carcinomac.697C>Tp.R233*0
26COSM5031079POLEendometrium,NS,carcinoma,endometrioid carcinomac.1307C>Gp.P436R0
27COSM774PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3139C>Tp.H1047Y0
28COSM5958PTENendometrium,NS,carcinoma,endometrioid carcinomac.165-1G>Tp.?0
29COSM5044PTENendometrium,NS,carcinoma,endometrioid carcinomac.397G>Ap.V133I0
30COSM5664CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.121A>Gp.T41A0
31COSM745PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.113G>Ap.R38H0
32COSM521KRASendometrium,NS,carcinoma,endometrioid carcinomac.35G>Ap.G12D0
33COSM5661CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.94G>Tp.D32Y0
34COSM5347032ARID1Aendometrium,NS,carcinoma,endometrioid carcinomac.2302G>Ap.G768S0
35COSM775PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3140A>Gp.H1047R0
36COSM51475ARID1Aendometrium,NS,carcinoma,endometrioid carcinomac.4582C>Tp.R1528*0
37COSM5087PTENendometrium,NS,carcinoma,endometrioid carcinomac.724G>Ap.E242K0
38COSM5667CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.134C>Tp.S45F0
39COSM773PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3129G>Tp.M1043I0
40COSM5677CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.98C>Gp.S33C0
41COSM5152PTENendometrium,NS,carcinoma,endometrioid carcinomac.388C>Tp.R130*0
42COSM533KRASendometrium,NS,carcinoma,endometrioid carcinomac.38G>Cp.G13A0
43COSM5679CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.110C>Gp.S37C0
44COSM33765AKT1endometrium,NS,carcinoma,endometrioid carcinomac.49G>Ap.E17K0
45COSM4169169KRASendometrium,NS,carcinoma,endometrioid carcinomac.413G>Ap.G138E0
46COSM520KRASendometrium,NS,carcinoma,endometrioid carcinomac.35G>Tp.G12V0
47COSM12461PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3062A>Gp.Y1021C0
48COSM10705TP53endometrium,NS,carcinoma,endometrioid carcinomac.586C>Tp.R196*0
49COSM746PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.263G>Ap.R88Q0
50COSM5033PTENendometrium,NS,carcinoma,endometrioid carcinomac.389G>Ap.R130Q0

Copy number variations for Endometrial Cancer from CNVD:

6 (show top 50)    (show all 66)
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1147991110230418110236367DuplicationGSTM1Endometrial cancer
2164301124300000247249719GainEndometrial cancer
3164311124300000247249719GainEndometrial cancer
4164431124300000247249719Gain or lossEndometrial cancer
53000512390000028000000Copy numberSTMN1Endometrial cancer
63817010140300000GainEndometrial cancer
73817310140300000Gain or lossEndometrial cancer
8428091040300000135374737GainEndometrial cancer
9428101040300000135374737Gain or lossEndometrial cancer
1047133108961317489718512Copy numberPTENEndometrial cancer
1147161108962319489728531LossPTENEndometrial cancer
124849511152900000Gain or lossEndometrial cancer
13554321152900000134452384Gain or lossEndometrial cancer
146153612135400000Gain or lossEndometrial cancer
1566123122535817925403863AmplificationKRASEndometrial cancer
16751501316000000114142980Gain or lossEndometrial cancer
17828141415600000106368585Gain or lossEndometrial cancer
18892411517000000100338915Gain or lossEndometrial cancer
199727416138200000GainEndometrial cancer
209727616138200000Gain or lossEndometrial cancer
21101463163820000088827254Gain or lossEndometrial cancer
2210679317122200000Gain or lossEndometrial cancer
23108760172220000078774742Gain or lossEndometrial cancer
2411917018116100000Gain or lossEndometrial cancer
25119734181610000076117153Gain or lossEndometrial cancer
2612409819128500000Gain or lossEndometrial cancer
27127175192850000063811651Gain or lossEndometrial cancer
281343552193300000Gain or lossEndometrial cancer
2914625624748376647760012RearrangementMSH2Endometrial cancer
30149784293300000242951149Gain or lossEndometrial cancer
3115041620127100000Gain or lossEndometrial cancer
32151944202710000062435964GainEndometrial cancer
33151953202710000062435964Gain or lossEndometrial cancer
34157114211230000046944323Gain or lossEndometrial cancer
35160291221180000049691432Gain or lossEndometrial cancer
36163141222437613924384284DuplicationGSTT1Endometrial cancer
371661553191700000Gain or lossEndometrial cancer
381720273175700000179000000AmplificationPIK3CAEndometrial cancer
3917501633700998237067341RearrangementMLH1Endometrial cancer
40179466391700000199501827Gain or lossEndometrial cancer
411799844150700000Gain or lossEndometrial cancer
42187532450700000191273063Gain or lossEndometrial cancer
43200012547700000180857866Gain or lossEndometrial cancer
442036996160500000Gain or lossEndometrial cancer
45214470660500000170899992Gain or lossEndometrial cancer
462171177159100000Gain or lossEndometrial cancer
47226563759100000158821424Gain or lossEndometrial cancer
482308338145200000Gain or lossEndometrial cancer
49240068845200000146274826GainEndometrial cancer
50240080845200000146274826Gain or lossEndometrial cancer

Expression for genes affiliated with Endometrial Cancer

About this section
Search GEO for disease gene expression data for Endometrial Cancer.

Pathways for genes affiliated with Endometrial Cancer

About this section

Pathways related to Endometrial Cancer according to GeneCards Suite gene sharing:

(show top 50)    (show all 106)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
10.3MLH1, MLH3, MSH2, MSH3, MSH6
210.3EGF, EGFR, FGFR2, KRAS
310.3CDH1, CTNNB1, EGF, EGFR
410.3CCND1, CDH1, CTNNB1, PIK3CA
510.3EGF, EGFR, KRAS, PIK3CA
610.3CCND1, ESR1, ESR2, KRAS
710.3EGFR, MLH1, MSH2, PTEN, TP53
810.3CCND1, CDH1, CTNNB1, KRAS, TP53
910.3CDH1, EGF, EGFR, ERBB2, PIK3CA
1010.3CDH1, CTNNB1, EGFR, ERBB2, TGFBR2
1110.3EGF, EGFR, KRAS, PIK3CA, TP53
12
Show member pathways
10.3CCND1, EGF, EGFR, ERBB2, KRAS
13
Show member pathways
10.3CCND1, KRAS, MLH1, MSH2, PTEN, TP53
14
Show member pathways
10.3CCND1, MSH2, MSH6, PIK3CA, PTEN, TP53
1510.3CCND1, CTNNB1, ESR1, TGFBR2, TP53
16
Show member pathways
10.3EGF, EGFR, ERBB2, KRAS, PIK3CA, PTEN
1710.2CDH1, CTNNB1, EGF, EGFR, ERBB2, TP53
18
Show member pathways
10.2CTNNB1, EGFR, ERBB2, FGFR2, KRAS, PTEN
1910.2CCND1, CTNNB1, ESR1, KRAS, PIK3CA, TP53
2010.2EGFR, ERBB2, FGFR2, KRAS, PIK3CA, PTEN
21
Show member pathways
10.2CCND1, ERBB2, ESR1, ESR2, KRAS, PIK3CA
22
Show member pathways
10.2CCND1, EGFR, ERBB2, FGFR2, KRAS, PTEN
2310.2CCND1, CTNNB1, KRAS, PIK3CA, TGFBR2, TP53
24
Show member pathways
10.2CCND1, ESR1, ESR2, MSH2, MSH3, MSH6
25
Show member pathways
10.2CDH1, CTNNB1, EGF, EGFR, FGFR2, KRAS
2610.2CCND1, EGFR, ERBB2, KRAS, PIK3CA, PTEN
2710.2CCND1, CDH1, EGF, EGFR, ERBB2, KRAS
2810.2CCND1, CTNNB1, EGF, EGFR, KRAS, PTEN
29
Show member pathways
10.2CDH1, EGF, EGFR, FGFR2, KRAS, PIK3CA
30
Show member pathways
10.2CDH1, CTNNB1, ERBB2, ESR1, KRAS, PIK3CA
31
Show member pathways
10.2CCND1, EGF, EGFR, ERBB2, KRAS, PIK3CA
32
Show member pathways
10.2CCND1, EGF, EGFR, KRAS, PIK3CA, PTEN
33
Show member pathways
10.2CCND1, EGF, EGFR, ERBB2, ESR1, ESR2
3410.2CCND1, EGF, EGFR, FGFR2, KRAS, PIK3CA
35
Show member pathways
10.2CCND1, CTNNB1, EGF, EGFR, ERBB2, KRAS
36
Show member pathways
10.2CTNNB1, EGFR, ERBB2, FGFR2, KRAS, PIK3CA
37
Show member pathways
10.2CCND1, CTNNB1, EGFR, ESR1, ESR2, KRAS
3810.2CCND1, CTNNB1, EGFR, ERBB2, ESR1, KRAS
39
Show member pathways
10.1CCND1, CTNNB1, EGF, EGFR, ERBB2, PIK3CA
40
Show member pathways
10.1CDH1, CTNNB1, EGF, EGFR, ERBB2, ESR1
41
Show member pathways
10.1CCND1, EGF, EGFR, ERBB2, KRAS, PIK3CA
42
Show member pathways
10.1CTNNB1, EGF, EGFR, ERBB2, FGFR2, KRAS
43
Show member pathways
10.1CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
4410.1CCND1, CDH1, CTNNB1, EGFR, ESR1, KRAS
45
Show member pathways
10.0CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
4610.0CCND1, CTNNB1, EGF, EGFR, ERBB2, ESR1
4710.0CCND1, CDH1, CTNNB1, EGF, EGFR, KRAS
48
Show member pathways
10.0CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
49
Show member pathways
9.9CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
509.9CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2

GO Terms for genes affiliated with Endometrial Cancer

About this section

Cellular components related to Endometrial Cancer according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1MutSalpha complexGO:003230111.2MSH2, MSH6
2MutSbeta complexGO:003230211.2MSH2, MSH3
3chiasmaGO:000571211.2MLH1, MLH3
4flotillin complexGO:001660011.0CDH1, CTNNB1
5catenin complexGO:001634211.0CDH1, CTNNB1
6apical junction complexGO:004329611.0CDH1, CTNNB1
7receptor complexGO:004323510.9EGF, EGFR, ERBB2, TGFBR2
8perinuclear region of cytoplasmGO:004847110.6CDH1, CTNNB1, EGFR, ERBB2, ESR1, ESR2
9membraneGO:001602010.2CCND1, CTNNB1, EGFR, ESR1, FGFR2, KRAS
10plasma membraneGO:000588610.0CDH1, CTNNB1, EGF, EGFR, ERBB2, ESR1
11nucleoplasmGO:00056549.8CCND1, CTNNB1, ESR1, ESR2, FGFR2, MLH1

Biological processes related to Endometrial Cancer according to GeneCards Suite gene sharing:

(show top 50)    (show all 69)
idNameGO IDScoreTop Affiliating Genes
1somatic recombination of immunoglobulin genes involved in immune responseGO:000220411.2MLH1, MSH2
2meiotic mismatch repairGO:000071011.2MSH2, MSH3, MSH6
3prostate epithelial cord arborization involved in prostate glandular acinus morphogenesisGO:006052711.1ESR1, FGFR2
4prostate epithelial cord elongationGO:006052311.1ESR1, FGFR2
5somatic hypermutation of immunoglobulin genesGO:001644611.1MLH1, MSH2, MSH6
6somatic recombination of immunoglobulin gene segmentsGO:001644711.1MLH1, MSH2, MSH6
7maintenance of DNA repeat elementsGO:004357011.1MSH2, MSH3, MSH6
8negative regulation of DNA recombinationGO:004591011.1MSH2, MSH3, MSH6
9determination of adult lifespanGO:000834011.1MSH2, MSH6, TP53
10mismatch repairGO:000629811.0MLH1, MLH3, MSH2, MSH3, MSH6
11response to UV-AGO:007014111.0CCND1, EGFR
12positive regulation of helicase activityGO:005109611.0MSH2, MSH3, MSH6
13isotype switchingGO:004519011.0MLH1, MSH2, MSH6
14response to X-rayGO:001016511.0CCND1, MSH2, TP53
15intrinsic apoptotic signaling pathway in response to DNA damageGO:000863011.0MLH1, MSH2, MSH6
16cellular response to indole-3-methanolGO:007168110.9CDH1, CTNNB1
17mesenchymal cell proliferation involved in lung developmentGO:006091610.9CTNNB1, FGFR2
18phosphatidylinositol phosphorylationGO:004685410.9EGF, EGFR, ERBB2, FGFR2, PIK3CA
19trachea morphogenesisGO:006043910.9CTNNB1, TGFBR2
20regulation of phosphatidylinositol 3-kinase signalingGO:001406610.9EGF, EGFR, ERBB2, FGFR2, PIK3CA
21positive regulation of mesenchymal cell proliferationGO:000205310.9CTNNB1, FGFR2, TGFBR2
22negative regulation of neuron deathGO:190121510.9CTNNB1, ESR1, ESR2
23positive regulation of protein phosphorylationGO:000193410.8CCND1, EGFR, ERBB2, KRAS
24cellular response to estradiol stimulusGO:007139210.8EGFR, ESR1, ESR2
25phosphatidylinositol-mediated signalingGO:004801510.8EGF, EGFR, ERBB2, FGFR2, PIK3CA, PTEN
26mammary gland alveolus developmentGO:006074910.8CCND1, EGF, ESR1
27ERBB2 signaling pathwayGO:003812810.8EGF, EGFR, ERBB2, KRAS, PIK3CA
28peptidyl-tyrosine phosphorylationGO:001810810.8EGF, EGFR, ERBB2, FGFR2
29positive regulation of sequence-specific DNA binding transcription factor activityGO:005109110.8CTNNB1, ESR1, ESR2, PTEN
30epidermal growth factor receptor signaling pathwayGO:000717310.8EGF, EGFR, KRAS, PIK3CA
31regulation of cell motilityGO:200014510.8EGF, EGFR, ERBB2
32reciprocal meiotic recombinationGO:000713110.8MLH1, MLH3, MSH2, MSH3, MSH6
33positive regulation of MAP kinase activityGO:004340610.8EGF, EGFR, ERBB2, KRAS
34embryonic cranial skeleton morphogenesisGO:004870110.8CTNNB1, FGFR2, TGFBR2
35cellular response to DNA damage stimulusGO:000697410.7CCND1, MLH1, MLH3, MSH2, TP53
36lung developmentGO:003032410.7CTNNB1, EGFR, FGFR2, TGFBR2
37response to organic substanceGO:001003310.7CCND1, CDH1, PTEN, TGFBR2
38response to organic cyclic compoundGO:001407010.7CCND1, EGFR, PTEN, TGFBR2
39canonical Wnt signaling pathwayGO:006007010.7CCND1, CTNNB1, EGF, PTEN
40response to estrogenGO:004362710.7CCND1, CTNNB1, ESR1, ESR2, TGFBR2
41MAPK cascadeGO:000016510.7EGF, EGFR, ERBB2, FGFR2, KRAS
42liver developmentGO:000188910.7CCND1, CTNNB1, EGFR, KRAS, PIK3CA
43positive regulation of epithelial cell proliferationGO:005067910.7EGFR, ERBB2, ESR1, FGFR2
44positive regulation of transcription, DNA-templatedGO:004589310.6CDH1, CTNNB1, EGF, ESR1, ESR2, TP53
45response to estradiolGO:003235510.5CCND1, CTNNB1, EGFR, ESR1, PTEN
46positive regulation of ERK1 and ERK2 cascadeGO:007037410.4EGFR, ESR1, ESR2, FGFR2, PTEN
47learning or memoryGO:000761110.4EGFR, ESR2, PTEN
48response to drugGO:004249310.3CCND1, CDH1, CTNNB1, PTEN, TGFBR2
49positive regulation of cell proliferationGO:000828410.1CCND1, CTNNB1, EGF, EGFR, FGFR2, KRAS
50positive regulation of transcription from RNA polymerase II promoterGO:00459449.9CTNNB1, EGFR, ESR1, ESR2, FGFR2, PGR

Molecular functions related to Endometrial Cancer according to GeneCards Suite gene sharing:

(show all 30)
idNameGO IDScoreTop Affiliating Genes
1single thymine insertion bindingGO:003214311.3MSH2, MSH6
2dinucleotide repeat insertion bindingGO:003218111.2MSH2, MSH3
3RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA bindingGO:003805211.2ESR1, ESR2
4single guanine insertion bindingGO:003214211.2MSH2, MSH3, MSH6
5dinucleotide insertion or deletion bindingGO:003213911.2MSH2, MSH3
6estrogen receptor activityGO:003028411.2ESR1, ESR2
7oxidized purine DNA bindingGO:003235711.2MSH2, MSH3, MSH6
8guanine/thymine mispair bindingGO:003213711.2MLH1, MSH2, MSH3, MSH6
9receptor signaling protein tyrosine kinase activityGO:000471611.2EGFR, ERBB2
10estrogen response element bindingGO:003405611.2ESR1, ESR2
11MutLalpha complex bindingGO:003240511.2MSH2, MSH6
12mismatched DNA bindingGO:003098311.1MLH3, MSH2, MSH3, MSH6
13centromeric DNA bindingGO:001923711.1MLH3, MSH2
14steroid hormone receptor activityGO:000370711.1ESR1, ESR2, PGR
15nitric-oxide synthase regulator activityGO:003023511.1EGFR, ESR1
16core promoter sequence-specific DNA bindingGO:000104611.0ESR1, ESR2, TP53
17phosphatidylinositol-4,5-bisphosphate 3-kinase activityGO:004693411.0EGF, EGFR, ERBB2, FGFR2, PIK3CA
18steroid bindingGO:000549611.0ESR1, ESR2, PGR
19protein tyrosine kinase activityGO:000471311.0EGF, EGFR, ERBB2, FGFR2
20damaged DNA bindingGO:000368411.0MSH2, MSH3, MSH6, TP53
21single-stranded DNA bindingGO:000369710.9MLH1, MLH3, MSH2, MSH3
22Ras guanyl-nucleotide exchange factor activityGO:000508810.9EGF, EGFR, ERBB2, FGFR2
23double-stranded DNA bindingGO:000369010.8CTNNB1, EGFR, MSH2, MSH6, TP53
24ATPase activityGO:001688710.8MLH1, MLH3, MSH2, MSH6
25protein phosphatase bindingGO:001990310.7CTNNB1, EGFR, ERBB2, TP53
26protein kinase bindingGO:001990110.6CCND1, CTNNB1, EGFR, MSH2, PTEN, TP53
27enzyme bindingGO:001989910.5CCND1, CTNNB1, EGFR, ESR1, ESR2, MSH2
28chromatin bindingGO:000368210.5CTNNB1, EGFR, ESR1, MLH1, MLH3, MSH6
29ATP bindingGO:000552410.3EGFR, ERBB2, FGFR2, MLH1, MLH3, MSH2
30protein bindingGO:00055159.8CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2

Sources for Endometrial Cancer

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet